Your session is about to expire
← Back to Search
Erector Spinae Nerve Block for Thoracic Surgery
Study Summary
This trial will compare the efficacy, safety, and side-effect profile of continuous erector spinae plane analgesia (ESP) versus continuous paravertebral analgesia (PVB) for video-assisted thoracic surgery (VATS).
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What risks do the patients involved in this treatment regimen face?
"The safety profile of this treatment has been thoroughly assessed, and is thus assigned a score of 3. This Phase 4 trial ensures the approved status for patient use."
Are there still opportunities for patients to partake in this experiment?
"Affirmative. Clinicaltrials.gov confirms that this medical trial, initially posted on March 11th 2019 is presently recruiting patients. 60 participants from 1 site need to be enrolled in the study."
What is the maximum capacity for enrollees in this trial?
"Affirmative. The particulars of this medical trial, which was published on March 11th 2019, are available on clinicaltrials.gov and the study is currently looking for 60 participants from a single research centre."
What are the core goals of this medical experiment?
"This clinical trial has one primary objective: to measure total opioid consumption over a 24 hour period after the catheter is removed. The secondary objectives include determining length of hospital stay, amount achieved on incentive spirometer device (mL), and any reported adverse events or complications with nerve block catheter placement such as pneumothorax, infections, bleeding, and local anesthetic toxicity."
Share this study with friends
Copy Link
Messenger